Show simple item record

dc.creatorNaicker, Dshanta D.
dc.creatorWerner, Lise.
dc.creatorKormuth, Emil.
dc.creatorPassmore, Jo-Ann.
dc.creatorMlisana, Koleka.
dc.creatorAbdool Karim, Salim Safurdeen.
dc.creatorNdung'u, Thumbi.
dc.date.accessioned2012-11-14T08:04:41Z
dc.date.available2012-11-14T08:04:41Z
dc.date.created2008
dc.date.issued2009
dc.identifier.citationNaicker D.D., Werner L., Kormuth E., et al. 2009. Interleukin-10 promoter polymorphisms influence HIV-1 susceptibility and primary HIV-1 pathogenesis. J Infect Dis 200, pp.448–452.en
dc.identifier.issn1537-6613
dc.identifier.urihttp://dx.doi.org/10.1086/600072en
dc.identifier.urihttp://hdl.handle.net/10413/7846
dc.description.abstractInterleukin (IL)–10 directly inhibits human immunodeficiency virus type 1 (HIV-1) replication, but it may also promote viral persistence by inactivation of effector immune mechanisms. Here, we show in an African cohort that individuals with genotypes associated with high IL-10 production at 2 promoter single-nucleotide polymorphisms ( 1082 and 592) were less likely to become HIV-1 infected but had significantly higher median plasma viral loads during the acute phase ( 3 months after infection). However, as the infection progressed, the association between genotype and median viral load was reversed. Thus, IL-10 may influence HIV-1 susceptibility and pathogenesis, but effects on the latter may differ according to the infection phase.en
dc.language.isoenen
dc.publisherThe Infectious Diseases Society of America.en
dc.subjectInterleukin-10.en
dc.subjectHIV infections--Genetic aspects.en
dc.titleInterleukin-10 Promoter Polymorphisms Influence HIV-1 Susceptibility and Primary HIV-1 Pathogenesis.en
dc.typePeer reviewed journal articleen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record